Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148638517> ?p ?o ?g. }
- W2148638517 endingPage "243" @default.
- W2148638517 startingPage "234" @default.
- W2148638517 abstract "The Androgen Receptor (AR) is a potential prognostic marker and therapeutic target in breast cancer. We evaluated AR protein expression in high-risk breast cancer treated in the adjuvant setting. Tumors were subtyped into luminal (ER+/PgR±/AR±), molecular apocrine (MAC, [ER−/PgR−/AR+]) and hormone receptor negative carcinomas (HR-negative, [ER−/PgR−/AR−]). Subtyping was evaluated with respect to prognosis and to taxane therapy. High histologic grade (p < 0.001) and increased proliferation (p = 0.001) more often appeared in MAC and HR-negative than in luminal tumors. Patients with MAC had outcome comparable to the luminal group, while patients with HR-negative disease had increased risk for relapse and death. MAC outcome was favorable upon taxane-containing treatment; this remained significant upon multivariate analysis for overall survival (HR 0.31, 95%CI 0.13–0.74, interaction p = 0.035) and as a trend for time to relapse (p = 0.15). In conclusion, AR-related subtyping of breast cancer may be prognostic and serve for selecting optimal treatment combinations." @default.
- W2148638517 created "2016-06-24" @default.
- W2148638517 creator A5001684767 @default.
- W2148638517 creator A5005181965 @default.
- W2148638517 creator A5005730021 @default.
- W2148638517 creator A5015437737 @default.
- W2148638517 creator A5027646786 @default.
- W2148638517 creator A5030925125 @default.
- W2148638517 creator A5044696839 @default.
- W2148638517 creator A5046379450 @default.
- W2148638517 creator A5046758725 @default.
- W2148638517 creator A5048212045 @default.
- W2148638517 creator A5049206234 @default.
- W2148638517 creator A5051365519 @default.
- W2148638517 creator A5078271543 @default.
- W2148638517 date "2014-06-01" @default.
- W2148638517 modified "2023-09-29" @default.
- W2148638517 title "The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping" @default.
- W2148638517 cites W1967761175 @default.
- W2148638517 cites W1974738527 @default.
- W2148638517 cites W1976263258 @default.
- W2148638517 cites W1976294122 @default.
- W2148638517 cites W1986175597 @default.
- W2148638517 cites W1989663680 @default.
- W2148638517 cites W1991834214 @default.
- W2148638517 cites W2011483165 @default.
- W2148638517 cites W2012140938 @default.
- W2148638517 cites W2017750947 @default.
- W2148638517 cites W2020234050 @default.
- W2148638517 cites W2043152591 @default.
- W2148638517 cites W2043814775 @default.
- W2148638517 cites W2044585736 @default.
- W2148638517 cites W2045886863 @default.
- W2148638517 cites W2048375037 @default.
- W2148638517 cites W2052014156 @default.
- W2148638517 cites W2053644910 @default.
- W2148638517 cites W2055572591 @default.
- W2148638517 cites W2056556973 @default.
- W2148638517 cites W2058132464 @default.
- W2148638517 cites W2070999370 @default.
- W2148638517 cites W2073618702 @default.
- W2148638517 cites W2085181480 @default.
- W2148638517 cites W2091205535 @default.
- W2148638517 cites W2095933146 @default.
- W2148638517 cites W2097255042 @default.
- W2148638517 cites W2098804778 @default.
- W2148638517 cites W2099744380 @default.
- W2148638517 cites W2108465670 @default.
- W2148638517 cites W2109497907 @default.
- W2148638517 cites W2110578052 @default.
- W2148638517 cites W2112237903 @default.
- W2148638517 cites W2123629153 @default.
- W2148638517 cites W2124919054 @default.
- W2148638517 cites W2127057139 @default.
- W2148638517 cites W2130598050 @default.
- W2148638517 cites W2131702935 @default.
- W2148638517 cites W2134539328 @default.
- W2148638517 cites W2136879321 @default.
- W2148638517 cites W2145909732 @default.
- W2148638517 cites W2146267790 @default.
- W2148638517 cites W2147343434 @default.
- W2148638517 cites W2155273887 @default.
- W2148638517 cites W2160085908 @default.
- W2148638517 cites W2162765338 @default.
- W2148638517 cites W2167624431 @default.
- W2148638517 cites W2171015116 @default.
- W2148638517 cites W3126209173 @default.
- W2148638517 doi "https://doi.org/10.1016/j.breast.2014.02.013" @default.
- W2148638517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24703723" @default.
- W2148638517 hasPublicationYear "2014" @default.
- W2148638517 type Work @default.
- W2148638517 sameAs 2148638517 @default.
- W2148638517 citedByCount "27" @default.
- W2148638517 countsByYear W21486385172014 @default.
- W2148638517 countsByYear W21486385172015 @default.
- W2148638517 countsByYear W21486385172016 @default.
- W2148638517 countsByYear W21486385172017 @default.
- W2148638517 countsByYear W21486385172018 @default.
- W2148638517 countsByYear W21486385172019 @default.
- W2148638517 countsByYear W21486385172020 @default.
- W2148638517 countsByYear W21486385172022 @default.
- W2148638517 countsByYear W21486385172023 @default.
- W2148638517 crossrefType "journal-article" @default.
- W2148638517 hasAuthorship W2148638517A5001684767 @default.
- W2148638517 hasAuthorship W2148638517A5005181965 @default.
- W2148638517 hasAuthorship W2148638517A5005730021 @default.
- W2148638517 hasAuthorship W2148638517A5015437737 @default.
- W2148638517 hasAuthorship W2148638517A5027646786 @default.
- W2148638517 hasAuthorship W2148638517A5030925125 @default.
- W2148638517 hasAuthorship W2148638517A5044696839 @default.
- W2148638517 hasAuthorship W2148638517A5046379450 @default.
- W2148638517 hasAuthorship W2148638517A5046758725 @default.
- W2148638517 hasAuthorship W2148638517A5048212045 @default.
- W2148638517 hasAuthorship W2148638517A5049206234 @default.
- W2148638517 hasAuthorship W2148638517A5051365519 @default.
- W2148638517 hasAuthorship W2148638517A5078271543 @default.
- W2148638517 hasBestOaLocation W21486385171 @default.
- W2148638517 hasConcept C121608353 @default.